Table 1 The relationship between Fdft1 expression and clinicopathological features in 81 CRC patients from FUSCC.

From: RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression

   

Fdft1

 
 

Variable

Number

Low expression

High expression

X2 test

     

P-value

Age (years)

<60

51

27

24

0.798

 

≥60

30

15

15

 

Gender

Female

60

33

27

0.338

 

Male

21

9

12

 

Tumor location

Colon

30

12

18

0.102

 

Rectum

51

30

21

 

Size

<5 cm

42

15

27

0.003*

 

≥5

39

27

12

 

Histological type

Adenocarcinoma

66

30

36

0.016*

 

Mucinous adenocarcinoma

15

12

3

 

Lymph node metastasis

No

42

12

30

0.000***

 

Yes

39

30

9

 

Tumor differentiation

Well, moderate

60

27

33

0.037*

 

Poor and others

21

15

6

 

Invasion

T1–2

21

6

15

0.013*

 

T3–4

60

36

24

 

Distant metastasis

No

75

36

39

0.043*

 

Yes

6

6

0

 

Clinical stage

I–II

30

9

21

0.003**

 

III–IV

51

33

18

 

CEA

< 5 ng/ml

54

24

30

0.059

 

≥5 ng/ml

27

18

9

 
  1. Pearson’s X2 tests were used. The results were considered statistically significant at P < 0.05. *P < 0.05, **P < 0.01, ***P < 0.001.
Back to article page